Mersana Therapeutics
MRSN
MRSN
132 hedge funds and large institutions have $1.14B invested in Mersana Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 45 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
38% less capital invested
Capital invested by funds: $1.83B → $1.14B (-$690M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
50% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 36
Holders
132
Holding in Top 10
3
Calls
$9.35M
Puts
$9.73M
Top Buyers
| 1 | +$24.9M | |
| 2 | +$24.7M | |
| 3 | +$18.1M | |
| 4 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$17.5M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$15M |
Top Sellers
| 1 | -$37.3M | |
| 2 | -$24.5M | |
| 3 | -$22.9M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$14.9M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$13M |